EZH2 and familial pancreatic carcinoma: miR-124 delivered by bone marrow mesenchymal stromal cell-derived exosomes can directly inhibit the expression of EZH2, and consequently suppress the malignant phenotypes of pancreatic tumor cells, and sensitizes pancreatic cancer cells to chemotherapy in vitro and in vivo (22).